Also, although smoking habits without TP53-CHIP carried a risk of respiratory disease mortality (HR, 1.91; (95% CI, 1.72–2.11), the risk was higher in the presence of TP53-CHIP (HR, 3.43; 95% CI, 2.73–4.30; Fig. 4A and B). Here, TP53 is linked to respiratory system disorder.